Cancer gene therapy

Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.

Cancer Gene Therapy 是癌症研究人员和临床医生必不可少的基因和细胞治疗资源，让读者了解癌症基因和细胞治疗的最新进展。 该期刊发表原始实验室和临床研究论文、病例报告和评论文章。出版主题包括RNAi方法、耐药性、造血祖细胞基因转移、癌症干细胞、细胞疗法、同源重组、核酶技术、反义技术、肿瘤免疫疗法和肿瘤抑制剂、转化研究、癌症治疗、基因传递系统（病毒和非病毒）、抗基因疗法（反义、siRNA和核酶）、细胞凋亡；机制和疗法、疫苗开发、免疫学和免疫治疗、DNA 合成和修复。